{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T02:07:04Z","timestamp":1789265224099,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"DOI":"10.1007\/s40261-026-01595-3","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T13:50:23Z","timestamp":1789221023000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Randomized Four-Period Cross-Over Phase I Study to Assess Bioavailability, Bioequivalence, and Tolerability of IHL-42X Compared with the Reference Drugs in Healthy Volunteers"],"prefix":"10.1007","author":[{"given":"George Williams","family":"Mbogo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Sallama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Asvadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emir","family":"Redzepagic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9717-7560","authenticated-orcid":false,"given":"Mark Robert","family":"Bleackley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"key":"1595_CR1","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.sleh.2017.04.003","volume":"3","author":"CN Kaufmann","year":"2017","unstructured":"Kaufmann CN, Susukida R, Depp CA. Sleep apnea, psychopathology, and mental health care. Sleep Health. 2017;3:244\u20139.","journal-title":"Sleep Health"},{"key":"1595_CR2","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1056\/NEJM199304293281704","volume":"328","author":"T Young","year":"1993","unstructured":"Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230\u20135.","journal-title":"N Engl J Med"},{"key":"1595_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.smrv.2016.07.002","volume":"34","author":"CV Senaratna","year":"2017","unstructured":"Senaratna CV, Perret JL, Lodge CJ, Lowe AJ, Campbell BE, Matheson MC, et al. Prevalence of obstructive sleep apnea in the general population: a systematic review. Sleep Med Rev. 2017;34:70\u201381.","journal-title":"Sleep Med Rev"},{"key":"1595_CR4","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/jsr.12430","volume":"25","author":"S Batool-Anwar","year":"2016","unstructured":"Batool-Anwar S, Goodwin JL, Kushida CA, Walsh JA, Simon RD, Nichols DA, et al. Impact of continuous positive airway pressure (CPAP) on quality of life in patients with obstructive sleep apnea (OSA). J Sleep Res. 2016;25:731\u20138.","journal-title":"J Sleep Res"},{"key":"1595_CR5","doi-asserted-by":"publisher","unstructured":"Wickwire EM, Capaldi II VF, Herrin J, Stryckman B, Thomas C, Williams SG, et al. Health and utilization burden of obstructive sleep apnea among U.S. active-duty military personnel. Chest [Internet] 2025. https:\/\/doi.org\/10.1016\/j.chest.2025.05.007. Accessed 21 Aug 2026.","DOI":"10.1016\/j.chest.2025.05.007"},{"key":"1595_CR6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.5665\/sleep.1724","volume":"35","author":"AG Wheaton","year":"2005","unstructured":"Wheaton AG, Perry GS, Chapman DP, Croft JB. Sleep disordered breathing and depression among U.S. adults: National Health and Nutrition Examination Survey, 2005\u20132008. Sleep. 2005;35:461\u20137.","journal-title":"Sleep"},{"key":"1595_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.smrv.2017.03.005","volume":"38","author":"M Olaithe","year":"2018","unstructured":"Olaithe M, Bucks RS, Hillman DR, Eastwood PR. Cognitive deficits in obstructive sleep apnea: insights from a meta-review and comparison with deficits observed in COPD, insomnia, and sleep deprivation. Sleep Med Rev. 2018;38:39\u201349. https:\/\/doi.org\/10.1016\/j.smrv.2017.03.005.","journal-title":"Sleep Med Rev"},{"key":"1595_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00702-015-1501-6","volume":"124","author":"K Krysta","year":"2017","unstructured":"Krysta K, Bratek A, Zawada K, Stepa\u0144czak R. Cognitive deficits in adults with obstructive sleep apnea compared to children and adolescents. J Neural Transm (Vienna). 2017;124:187\u2013201.","journal-title":"J Neural Transm (Vienna)"},{"key":"1595_CR9","first-page":"619","volume":"17","author":"RA Stoohs","year":"1994","unstructured":"Stoohs RA, Guilleminault C, Itoi A, Dement WC. Traffic accidents in commercial long-haul truck drivers: the influence of sleep-disordered breathing and obesity. Sleep. 1994;17:619\u201323.","journal-title":"Sleep"},{"key":"1595_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1378\/chest.94.1.9","volume":"94","author":"J He","year":"1988","unstructured":"He J, Kryger MH, Zorick FJ, Conway W, Roth T. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest. 1988;94:9\u201314.","journal-title":"Chest"},{"key":"1595_CR11","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/sleep\/31.5.593","volume":"31","author":"T Young","year":"2008","unstructured":"Young T, Finn L, Peppard PE, Szklo-Coxe M, Austin D, Nieto FJ, et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep. 2008;31:1071\u20138.","journal-title":"Sleep"},{"key":"1595_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.wjorl.2015.08.001","volume":"1","author":"M Knauert","year":"2015","unstructured":"Knauert M, Naik S, Gillespie MB, Kryger M. Clinical consequences and economic costs of untreated obstructive sleep apnea syndrome. World J Otorhinolaryngol Head Neck Surg. 2015;1:17\u201327.","journal-title":"World J Otorhinolaryngol Head Neck Surg"},{"key":"1595_CR13","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S2213-2600(19)30198-5","volume":"7","author":"AV Benjafield","year":"2019","unstructured":"Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7:687\u201398. https:\/\/doi.org\/10.1016\/S2213-2600(19)30198-5.","journal-title":"Lancet Respir Med"},{"key":"1595_CR14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.5664\/jcsm.6506","volume":"13","author":"VK Kapur","year":"2017","unstructured":"Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K, et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017;13:479\u2013504.","journal-title":"J Clin Sleep Med"},{"key":"1595_CR15","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1161\/CIRCULATIONAHA.107.189375","volume":"118","author":"JJ Goldberger","year":"2008","unstructured":"Goldberger JJ, Cain ME, Hohnloser SH, Kadish AH, Knight BP, Lauer MS, et al. American Heart Association\/American College of Cardiology Foundation\/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death. Circulation. 2008;118:1497\u2013518.","journal-title":"Circulation"},{"key":"1595_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.5664\/jcsm.7638","volume":"15","author":"SP Patil","year":"2019","unstructured":"Patil SP, Ayappa IA, Caples SM, Kimoff RJ, Patel SR, Harrod CG. Treatment of adult obstructive sleep apnea with positive airway pressure: an American Academy of Sleep Medicine Systematic Review, Meta-Analysis, and GRADE Assessment. J Clin Sleep Med. 2019;15:301\u201334.","journal-title":"J Clin Sleep Med"},{"key":"1595_CR17","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/aje\/kws342","volume":"177","author":"PE Peppard","year":"2013","unstructured":"Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177:1006\u201314.","journal-title":"Am J Epidemiol"},{"key":"1595_CR18","unstructured":"Frost & Sullivan. Hidden health crisis costing America Billions. Underdiagnosing and undertreating obstructive sleep apnea draining healthcare system. Darien Illinois. 2016. https:\/\/aasm.org\/wp-content\/uploads\/2017\/10\/sleep-apnea-economic-crisis.pdf. Accessed 21 Aug 2026."},{"key":"1595_CR19","doi-asserted-by":"crossref","unstructured":"Wickwire EM, Cole K V, Dexter RB, Malhotra A, Cistulli PA, Sterling KL, et al. Depression and comorbid obstructive sleep apnea: Association between positive airway pressure adherence, occurrence of self-harm events, healthcare resource utilization, and costs. J Affect Disord 2024;349:254\u201361. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0165032723015239. Accessed 21 Aug 2026.","DOI":"10.1016\/j.jad.2023.12.055"},{"key":"1595_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.12703\/r\/10-40","volume":"10","author":"EM Wickwire","year":"2021","unstructured":"Wickwire EM. Value-based sleep and breathing: health economic aspects of obstructive sleep apnea. Fac Rev. 2021;10:40.","journal-title":"Fac Rev"},{"key":"1595_CR21","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.5664\/jcsm.6034","volume":"12","author":"NF Watson","year":"2016","unstructured":"Watson NF. Health care savings: the economic value of diagnostic and therapeutic care for obstructive sleep apnea. J Clin Sleep Med. 2016;12:1075\u20137.","journal-title":"J Clin Sleep Med"},{"key":"1595_CR22","doi-asserted-by":"publisher","unstructured":"Wickwire EM, Albrecht JS, Towe MM, Abariga SA, Diaz-Abad M, Shipper AG, et al. The impact of treatments for OSA on monetized health economic outcomes: a systematic review. Chest 2019;155:947\u201361. https:\/\/doi.org\/10.1016\/j.chest.2019.01.009. Accessed 21 Aug 2026.","DOI":"10.1016\/j.chest.2019.01.009"},{"key":"1595_CR23","doi-asserted-by":"publisher","first-page":"210200","DOI":"10.1183\/16000617.0200-2021","volume":"30","author":"W Randerath","year":"2021","unstructured":"Randerath W, Verbraecken J, de Raaff CAL, Hedner J, Herkenrath S, Hohenhorst W, et al. European Respiratory Society guideline on non-CPAP therapies for obstructive sleep apnoea. Eur Respir Rev. 2021;30:210200.","journal-title":"Eur Respir Rev"},{"key":"1595_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(25)00002-5","author":"AV Benjafield","year":"2025","unstructured":"Benjafield AV, Pepin JL, Cistulli PA, Wimms A, Lavergne F, Sert Kuniyoshi FH, et al. Positive airway pressure therapy and all&cause and cardiovascular mortality in people with obstructive sleep apnoea: a systematic review and meta-analysis of randomised controlled trials and confounder-adjusted, non-randomised controlled studies. Lancet Respir Med. 2025. https:\/\/doi.org\/10.1016\/S2213-2600(25)00002-5.","journal-title":"Lancet Respir Med"},{"key":"1595_CR25","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1164\/rccm.201202-0200OC","volume":"186","author":"TE Weaver","year":"2012","unstructured":"Weaver TE, Mancini C, Maislin G, Cater J, Staley B, Landis JR, et al. Continuous positive airway pressure treatment of sleepy patients with milder obstructive sleep apnea: results of the CPAP Apnea Trial North American Program (CATNAP) randomized clinical trial. Am J Respir Crit Care Med. 2012;186:677\u201383.","journal-title":"Am J Respir Crit Care Med"},{"key":"1595_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/15402002.2013.778203","volume":"12","author":"B Rodgers","year":"2014","unstructured":"Rodgers B. Breaking through limbo: experiences of adults living with obstructive sleep apnea. Behav Sleep Med. 2014;12:183\u201397.","journal-title":"Behav Sleep Med"},{"key":"1595_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsy014","volume":"41","author":"SC Veasey","year":"2018","unstructured":"Veasey SC. Obstructive sleep apnea drug therapy: apnea\u2013hypopnea index leaves us high and dry. Sleep. 2018;41:zsy014. https:\/\/doi.org\/10.1093\/sleep\/zsy014.","journal-title":"Sleep"},{"key":"1595_CR28","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.sleep.2005.03.014","volume":"6","author":"C Guilleminault","year":"2005","unstructured":"Guilleminault C, Poyares D, Rosa A, Huang YS. Heart rate variability, sympathetic and vagal balance and EEG arousals in upper airway resistance and mild obstructive sleep apnea syndromes. Sleep Med. 2005;6:451\u20137.","journal-title":"Sleep Med"},{"key":"1595_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsae276","author":"J Walsh","year":"2025","unstructured":"Walsh J, Rankin T, Mehra S, Naughton MT, Roebuck T, McDermott E, et al. A randomized dose finding study of combination dronabinol and acetazolamide for the treatment of obstructive sleep apnea. Sleep. 2025. https:\/\/doi.org\/10.1093\/sleep\/zsae276.","journal-title":"Sleep"},{"key":"1595_CR30","unstructured":"FDA. Bioanalytical method validation: guidance for industry. Silver Spring\/Rockville. 2018. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/bioanalytical-method-validation-guidance-industry. Accessed 21 Aug 2026."},{"key":"1595_CR31","doi-asserted-by":"crossref","unstructured":"Carley DW, Prasad B, Reid KJ, Malkani R, Attarian H, Abbott SM, et al. Pharmacotherapy of apnea by cannabimimetic enhancement, the PACE clinical trial: effects of dronabinol in obstructive sleep apnea. Sleep 2018;41.","DOI":"10.1093\/sleep\/zsx184"},{"key":"1595_CR32","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1113\/jphysiol.2011.223925","volume":"590","author":"BA Edwards","year":"2012","unstructured":"Edwards BA, Sands SA, Eckert DJ, White DP, Butler JP, Owens RL, et al. Acetazolamide improves loop gain but not the other physiological traits causing obstructive sleep apnoea. J Physiol. 2012;590:1199\u2013211.","journal-title":"J Physiol"},{"key":"1595_CR33","doi-asserted-by":"crossref","unstructured":"Thomson LDJ, Landry SA, Maddison K, Walsh R, Bleackley MR, Hamilton GS, et al. The impact of acetazolamide and dronabinol on the physiological endotypes responsible for obstructive sleep apnea. Sleep Med [Internet] 2025;132:106542. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1389945725002114. Accessed 21 Aug 2026.","DOI":"10.1016\/j.sleep.2025.106542"},{"key":"1595_CR34","unstructured":"Alkem Laboratories Ltd: Marinol Drug Label. National Library of Medicine. https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=628f9609-6583-49be-be77-b64cfbc46fd7. Accessed 21 Aug 2026."},{"key":"1595_CR35","unstructured":"Micro Labs Limited: Acetazolamide Extended Release Capsules. National Library of Medicine. https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=78f78919-a6ba-4072-bc45-2ab3637ed894. Accessed 21 Aug 2026."},{"key":"1595_CR36","doi-asserted-by":"crossref","unstructured":"Kunka RL, Mattocks AM. Relationship of pharmacokinetics to pharmacological response for acetazolamide. J Pharm Sci. 1979;68:347\u20139. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0022354915425134. Accessed 21 Aug 2026.","DOI":"10.1002\/jps.2600680324"},{"key":"1595_CR37","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2174\/138161208783877884","volume":"14","author":"CT Supuran","year":"2008","unstructured":"Supuran CT. Carbonic anhydrases-an overview. Curr Pharm Des. 2008;14:603\u201314.","journal-title":"Curr Pharm Des"},{"key":"1595_CR38","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejim.2018.01.004","volume":"49","author":"CA MacCallum","year":"2018","unstructured":"MacCallum CA, Russo EB. Practical considerations in medical cannabis administration and dosing. Eur J Intern Med. 2018;49:12\u20139.","journal-title":"Eur J Intern Med"},{"key":"1595_CR39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/FBP.0000000000000592","volume":"33","author":"CF Moore","year":"2022","unstructured":"Moore CF, Stiltner JW, Davis CM, Weerts EM. Translational models of cannabinoid vapor exposure in laboratory animals. Behav Pharmacol. 2022;33:63\u201389.","journal-title":"Behav Pharmacol"},{"key":"1595_CR40","first-page":"155","volume":"8","author":"N Parikh","year":"2016","unstructured":"Parikh N, Kramer W, Khurana V, Cognata Smith C, Vetticaden S. Bioavailability study of dronabinol oral solution versus dronabinol capsules in healthy volunteers. Clin Pharmacol. 2016;8:155\u201362.","journal-title":"Clin Pharmacol"},{"key":"1595_CR41","first-page":"9","volume":"9","author":"DA Oh","year":"2017","unstructured":"Oh DA, Parikh N, Khurana V, Cognata Smith C, Vetticaden S. Effect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteers. Clin Pharmacol. 2017;9:9\u201317.","journal-title":"Clin Pharmacol"},{"key":"1595_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-04573-5","volume":"15","author":"GW Mbogo","year":"2025","unstructured":"Mbogo GW, Kroner P, Walsh R, Newchurch J, Bleackley MR. An open-label phase I comparator-controlled clinical trial to assess tolerability and pharmacokinetics of IHL-675 A a fixed dose combination of cannabidiol plus hydroxychloroquine in healthy volunteers. Sci Rep. 2025;15:19357.","journal-title":"Sci Rep"},{"key":"1595_CR43","doi-asserted-by":"crossref","unstructured":"Godfrey KR, Arundel PA, Dong Z, Bryant R. Modelling the double peak phenomenon in pharmacokinetics. Comput Methods Programs Biomed [Internet] 2011;104:62\u20139. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0169260710000593. Accessed 21 Aug 2026.","DOI":"10.1016\/j.cmpb.2010.03.007"},{"key":"1595_CR44","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/B978-1-4160-6189-2.00064-0","volume-title":"Sleisenger and Fordtran\u2019s gastrointestinal and liver disease- 2 volume set: pathophysiology, diagnosis, management, expert consult premium edition\u2014enhanced online features and print","author":"PA Dawson","year":"2010","unstructured":"Dawson PA. Bile secretion and the enterohepatic circulation. In: Sleisenger and Fordtran\u2019s gastrointestinal and liver disease- 2 volume set: pathophysiology, diagnosis, management, expert consult premium edition\u2014enhanced online features and print. 2010. p. 1075\u201388."},{"key":"1595_CR45","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1128\/AAC.00345-10","volume":"54","author":"SP Zvada","year":"2010","unstructured":"Zvada SP, Van Der Walt JS, Smith PJ, Fourie PB, Roscigno G, Mitchison D, et al. Effects of four different meal types on the population pharmacokinetics of single-dose rifapentine in healthy male volunteers. Antimicrob Agents Chemother. 2010;54:3390\u20134.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-026-01595-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-026-01595-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-026-01595-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T02:02:46Z","timestamp":1789264966000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-026-01595-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":45,"alternative-id":["1595"],"URL":"https:\/\/doi.org\/10.1007\/s40261-026-01595-3","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,12]]},"assertion":[{"value":"17 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"GWM, AS, PA, NM, and MRB are or were employees of Incannex Healthcare Pty Ltd and have shares in the company. ER and PR have no competing interests to declare that are relevant to the content of this article.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was carried out according to the principles of the Declaration of Helsinki, the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) Guideline for Good Clinical Practice (GCP) E6(R2) (2016) (as adopted in Australia), and the National Health and Medical Research Council National Statement on Ethical Conduct in Human Research (2007, incorporating all updates). The study protocol was approved (approval no. 2022-12-1434 dated 3 July 2023) by Bellberry Human Research and ethics committee (123 Glen Osmond Road, Eastwood, 5063, South Australia).","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from each subject before any trial-related procedures were performed\n                      .","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable\n                      .","order":5,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All data generated or analyzed during this study are included in this published article. The datasets generated during and\/or analyzed during the current study are related to a proprietary commercial formulation and as such will not be made available.","order":6,"name":"Ethics","label":"Data Availability Statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GWM, AS, PA, NM, and MRB contributed to the study design, data collection, analysis, interpretation, and manuscript preparation. ER and PR were study principal investigators who oversaw the study implementation, data collection, analysis, interpretation, and manuscript preparation. All authors read and approved the final version and submission of this manuscript.","order":7,"name":"Ethics","label":"Authors Contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}